Spots Global Cancer Trial Database for metastatic tumors
Every month we try and update this database with for metastatic tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors | NCT02156388 | Chemotherapy-in... Metastatic Tumo... | GW003 | 18 Years - 65 Years | Jiangsu T-Mab Biopharma Co.,Ltd | |
| Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases | NCT02933242 | Metastatic Tumo... | Stereotactic Ab... | 18 Years - | British Columbia Cancer Agency | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET) | NCT01446744 | Metastatic Tumo... | Stereotactic ab... palliative radi... | 18 Years - | Lawson Health Research Institute | |
| Study of E7389 in Patients With Advanced Solid Tumors | NCT00069264 | Advanced Solid ... | E7389 | 18 Years - | Eisai Inc. | |
| A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients | NCT01209832 | Advanced Cancer | Tasisulam Midazolam | 18 Years - | Eli Lilly and Company | |
| Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors | NCT00676949 | Metastatic Tumo... | 5 peptide vacci... | 20 Years - 80 Years | Kyushu University | |
| Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors | NCT05270213 | Advanced Cancer | RBS2418 | 18 Years - | Riboscience, LLC. | |
| A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma | NCT05390528 | Advanced Tumors Lymphoma Metastatic Tumo... | HLX301 | 18 Years - | Shanghai Henlius Biotech | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors | NCT03721341 | Metastatic Tumo... | Palliative Radi... Chemotherapy Immunotherapy Hormones Observation Stereotactic Ab... | 18 Years - | Lawson Health Research Institute | |
| Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases | NCT02933242 | Metastatic Tumo... | Stereotactic Ab... | 18 Years - | British Columbia Cancer Agency | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET) | NCT01446744 | Metastatic Tumo... | Stereotactic ab... palliative radi... | 18 Years - | Lawson Health Research Institute | |
| Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors | NCT05270213 | Advanced Cancer | RBS2418 | 18 Years - | Riboscience, LLC. | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer | NCT03862911 | Metastatic Tumo... | palliative radi... Stereotactic ab... | 18 Years - | British Columbia Cancer Agency | |
| Radiofrequency Ablation of Tumors | NCT00705497 | Primary Tumors Metastatic Tumo... | Radiofrequency ... | - | St. Jude Children's Research Hospital | |
| A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma | NCT05390528 | Advanced Tumors Lymphoma Metastatic Tumo... | HLX301 | 18 Years - | Shanghai Henlius Biotech | |
| Phase 1 Study of OTS167 in Patients With Solid Tumors | NCT01910545 | Solid Tumors Metastatic Tumo... | OTS167IV | 18 Years - | OncoTherapy Science, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
